TCAI also has conducted the first case using a second commercially approved PFA system. Credit: Gorodenkoff/Shutterstock.com.

The Texas Cardiac Arrhythmia Institute (TCAI) at St David’s Medical Center has implemented a new pulsed field ablation (PFA) system for treating patients with paroxysmal and persistent atrial fibrillation.

With this development, TCAI became the first in the US to use the PFA system for atrial fibrillation, a heart arrhythmia.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

The first procedure was conducted by electrophysiologists Dr Andrea Natale and Dr Amin Al-Ahmad using the system after it received approval from the US Food and Drug Administration (FDA).

TCAI cardiac electrophysiologist and executive medical director Andrea Natale said: “This historic milestone represents the biggest advancement in the electrophysiology field in decades, as it will allow patients to be treated more safely and effectively, ultimately restoring their quality of life.

“Our team is honoured to have played a part in piloting this new era of global innovation for cardiac arrhythmia.”

See Also:

The PFA system operates by delivering short, high-energy electrical pulses to the cardiac tissue, effectively destroying cells that cause irregular heart rhythms.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Dr Natale and Dr Al-Ahmad were among the 67 worldwide operators who participated in the trial, which led to the system’s FDA approval.

Additionally, TCAI has conducted the first case using a second commercially approved PFA system.

This system features an adaptable ablation catheter to fit various patient anatomies.

Joseph Gallinghouse, a clinical cardiac electrophysiologist, performed this procedure.

In 2022, electrophysiologists at the TCAI marked a milestone by performing 3,000 robotic cardiac ablation procedures and the majority of them treated ventricular tachycardia.

TCAI has a 72,000ft² robotic electrophysiology centre, which includes six electrophysiology labs that feature advanced technology to treat complex arrhythmias.